The Role of N-acetyl-l-cysteine (NAC) as an Adjuvant to Opioid Treatment in Patients With Chronic Neuropathic Pain
Status:
Completed
Trial end date:
2017-04-01
Target enrollment:
Participant gender:
Summary
This study will test whether treatment with N-acetyl-L-cysteine (NAC) is safe and decreases
pain in patients with chronic neuropathic pain. The investigators hypothesize that NAC will
be a useful adjunct to opioid treatment in chronic neuropathic pain.